AstraZeneca today announced $1.6 million in grants to nonprofit organizations across the US through its Accelerate Change Together (ACT) on Health Equity initiative. The initiative supports programs ...
The AstraZeneca Foundation today announced $1,144,170 in grants through its signature Creating Health Access for Next Generation Equity (CHANGE) program, including funding for five new nonprofit ...
To send your request to the US Information Center at AstraZeneca, please fill out the form below. The information you submit will be governed by our privacy policy.
At AstraZeneca, we are committed to building healthier, more resilient communities across the United States. Through our US Contributions Program, we partner with non-profit organizations whose ...
Exercising due diligence to prevent, detect and correct unlawful conduct Promoting an organizational culture that encourages ethical conduct and compliance with law. In addition to these fundamental ...
Exploratory analyses of the POTOMAC Phase III trial showed adding one year of treatment with AstraZeneca’s IMFINZI® (durvalumab) to BCG induction and maintenance therapy reduced the number of ...
Landmark results from the DeLLphi-305 Phase III trial showed IMFINZI ® (durvalumab) plus Amgen’s tarlatamab-dlle demonstrated a statistically significant and highly clinically meaningful improvement ...
AstraZeneca today announced the US availability of ZEGFROVY ® (sunvozertinib) for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have ...
Positive high-level results from the SAFFRON Phase III trial showed TAGRISSO ® (osimertinib) plus savolitinib demonstrated a statistically significant and clinically meaningful improvement in both ...
The US Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) did not reach a majority vote in favor of the benefit risk profile of AstraZeneca’s camizestrant in combination ...
FLUMIST® (Influenza Vaccine Live, Intranasal) Now Available in the US for the 2026–2027 Flu Season
Needle-free influenza vaccine option is available through healthcare settings or via FluMist Home for at-home administration. AstraZeneca today announces that FLUMIST® (Influenza Vaccine Live, ...
AstraZeneca advances its ambition to eliminate cancer as a cause of death and transform outcomes for people living with rare diseases with new data across its diverse, industry-leading portfolio and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results